BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 11517754)

  • 1. [Effectiveness and tolerance of celebrex in osteoarthrosis (data of a Russian study)].
    Tsvetkova ES; Alekseeva LI; Balabanova RM; Chichasova NV; Shostak NA; Shmidt EI
    Ter Arkh; 2001; 73(5):61-3. PubMed ID: 11517754
    [No Abstract]   [Full Text] [Related]  

  • 2. [Gastroduodenal tolerance of celecoxib (celebrex) in patients with osteoarthrosis: an endoscopic evaluation].
    Karateev AE
    Ter Arkh; 2001; 73(5):63-4. PubMed ID: 11517755
    [No Abstract]   [Full Text] [Related]  

  • 3. [Celebrex: confirmed effectiveness and safety (new data)].
    Nasonov EL
    Ter Arkh; 2001; 73(5):57-61. PubMed ID: 11517753
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
    Nasonova VA
    Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
    [No Abstract]   [Full Text] [Related]  

  • 5. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastrointestinal complications caused by NSAIDs. Over 60% of arthrosis patients are endangered].
    MMW Fortschr Med; 2003 Mar; 145(10):60. PubMed ID: 12688036
    [No Abstract]   [Full Text] [Related]  

  • 7. [Interactions of nonsteroid anti-inflammatory drugs with inhibitors of angiotensin-converting enzyme in patients with rheumatic diseases (a review)].
    Tsurko VV; Preobrazhenskiĭ DV; Ob ukhova OA
    Ter Arkh; 2003; 75(5):64-70. PubMed ID: 12847902
    [No Abstract]   [Full Text] [Related]  

  • 8. Tramadol pharmacokinetics and its possible interactions with cyclooxygenase 2-selective nonsteroidal anti-inflammatory drugs.
    Punwani NG
    Clin Pharmacol Ther; 2004 Apr; 75(4):363-5. PubMed ID: 15060515
    [No Abstract]   [Full Text] [Related]  

  • 9. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G; Cravero E
    Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cox-2 inhibitors in the focus. Rofecoxib as effective as the "classics"].
    MMW Fortschr Med; 2001 Nov; 143(46):50-1. PubMed ID: 11759601
    [No Abstract]   [Full Text] [Related]  

  • 11. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective COX-2 inhibition.
    Silas S; Clegg DO
    Bull Rheum Dis; 1999; 48(2):1-4. PubMed ID: 12024416
    [No Abstract]   [Full Text] [Related]  

  • 13. Efficacy and safety of diclofenac-cholestyramine and celecoxib in osteoarthritis.
    Suárez-Otero R; Robles-San Román M; Jaimes-Hernández J; Oropeza-De La Madrid E; Medina-Peñaloza RM; Rosas-Ramos R; Castañeda-Hernández G
    Proc West Pharmacol Soc; 2002; 45():26-8. PubMed ID: 12434517
    [No Abstract]   [Full Text] [Related]  

  • 14. Celecoxib-induced upper gastrointestinal hemorrhage and ulceration.
    Crawford AS; White JG
    South Med J; 2002 Dec; 95(12):1444-6. PubMed ID: 12597315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the baseline cardiovascular risk profile among hypertensive patients prescribed COX-2-specific inhibitors or nonspecific NSAIDs: data from real-life practice.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S392-400. PubMed ID: 12416789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial patterns of use of COX-2 inhibitors by elderly patients in Ontario: findings and implications.
    Mamdani M; Rochon P; Laupacis A; Anderson G
    CMAJ; 2002 Nov; 167(10):1125-6. PubMed ID: 12427703
    [No Abstract]   [Full Text] [Related]  

  • 17. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current post-marketing information. Effects and adverse effects of celecoxib].
    Schmidt H; Geisslinger G
    Pharm Unserer Zeit; 2002; 31(2):180-7. PubMed ID: 11977454
    [No Abstract]   [Full Text] [Related]  

  • 19. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 20. [Pharma-clinics. The drug of the month. Celecoxib (Celebrex)].
    Scheen AJ
    Rev Med Liege; 2001 Jan; 56(1):53-5. PubMed ID: 11256140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.